Skip to main content
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational breast cancer research consortium trial 017: De Los Santos JF, Cantor A, Amos KD, et al (Univ of Alabama at Birmingham Comprehensive Cancer Ctr; Univ of North Carolina Chapel Hill; Et al) Cancer 119:1776-1783, 2013
- Author(s): Su, MYL;
- et al.
Published Web Locationhttps://doi.org/10.1016/j.breastdis.2013.10.011
For improved accessibility of PDF content, download the file to your device.